Gout

Disease ID:1027
Name:Gout
Associated with:1 targets
0 immuno-relevant targets
3 immuno-relevant ligands
Database Links
Disease Ontology: DOID:13189

Targets

Ligands

Ligand Approved Immuno References Clinical comments
etoricoxib  [  (Drugs.com) ]
Clinical Use: Used in the treatment of rheumatoid arthritis, osteoarthritis, chronic lower back pain, ankylosing spondylitis, acute pain and gout. There is no information regarding approval for medicinal use of etoricoxib on the US FDA website. Individual national agencies may have granted marketing approval.
Immuno Disease Comments: Selective COX2 inhibitor approved for the treatment of many inflammatory conditions including gout.
naproxen  [  (Drugs.com) ]
Clinical Use: Used in the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis, and acute gout. Also used in pain relief in the treatment of primary dysmenorrhea.
Immuno Disease Comments: Approved NSAID used for acute gout.
sulindac  [  (Drugs.com) ]
Clinical Use: For acute relief or long term use in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute painful shoulder and acute gouty arthritis.
Immuno Disease Comments: Approved drug for gout.